Why Choose Us
Why Choose UsPatients with non-Hodgkin’s lymphoma from across the world come to NewYork-Presbyterian for treatment. Our lymphoma experts are among the few teams nationwide and worldwide who have deciphered the basic science behind lymphoma development, patented lymphoma drugs, and directed national and international clinical trials leading to the domestic and international approval of new therapies.
Our Team
Our TeamFor decades, NewYork-Presbyterian has been conducting research leading to more effective treatments that are less toxic and enable people with lymphoma to live longer and feel better. Through our clinical and basic science research programs, we have played a pivotal role in developing many new drugs recently approved for the disease. In some cases, our physicians and scientists have invented and led the international teams who paved the way for the approval of new treatments for select subtypes of lymphoma.
Expertise and leadership in T-cell lymphomas
Conventional chemotherapy regimens are markedly inadequate for T-cell lymphomas. Our non-Hodgkin's lymphoma specialists are leveraging developments in biology and experimental therapies to create novel initial treatments. Our physicians have developed studies for these diseases where member institutions will be accruing patients for these innovative clinical trials and hasten the development of better treatments for peripheral T-cell lymphoma (PTCL).
Our Approach to Blood Cancer Care
Our Approach to CareThere are more than 70 distinct types of non-Hodgkin’s lymphoma and many different types of treatment, depending on the type, stage, and biology of your cancer. At NewYork-Presbyterian, our lymphoma specialists begin by identifying your exact type of non-Hodgkin’s lymphoma and customizing a treatment plan for you. We take the time to help you understand your treatment choices to make an informed decision about what is best for you. Our ultimate goal is to find a cure for your disease.
Clinical Trials
Clinical TrialsAs leaders in the field of lymphomas, such as non-Hodgkin's lymphoma and Hodgkin's lymphoma, we offer an extensive portfolio of clinical trials for people with this disease.
- Our team of lymphoma experts has invented new lymphoma drugs and led their clinical development. They have also directed international studies to approve these therapies in other countries.
- You may have the opportunity to participate in a clinical trial assessing a promising new therapy
Learn more information about our clinical trials and how you might benefit.
Get Care for Non-Hodgkin's Lymphoma from NewYork-Presbyterian
At NewYork-Presbyterian, we treat the whole person. Through our matrix cancer centers, you'll have access to the complete resources of our top-ranked academic medical centers, including specialists from all areas who collaborate with our cancer experts to provide comprehensive care. This collaboration makes NewYork-Presbyterian an excellent choice for people with non-Hodgkin’s lymphoma.